A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK<sup>®</sup>) lowering cardiovascular disease risk
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.